Tilray Brands, Inc. (NASDAQ:TLRY) Receives Consensus Recommendation of “Hold” from Analysts

Shares of Tilray Brands, Inc. (NASDAQ:TLRY) have been given a consensus recommendation of “Hold” by the eight analysts that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, six have issued a hold recommendation and one has issued a buy recommendation on the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $13.3333.

Several research analysts have recently weighed in on the company. Zacks Research raised Tilray Brands from a “strong sell” rating to a “hold” rating in a research note on Wednesday, February 11th. Weiss Ratings reissued a “sell (d-)” rating on shares of Tilray Brands in a research note on Wednesday, January 21st. Roth Mkm cut their price target on shares of Tilray Brands from $20.00 to $10.00 and set a “neutral” rating for the company in a report on Tuesday, January 20th. Canaccord Genuity Group assumed coverage on shares of Tilray Brands in a research report on Tuesday, January 27th. They set a “hold” rating for the company. Finally, ATB Cormark Capital Markets raised shares of Tilray Brands from a “strong sell” rating to a “hold” rating in a report on Wednesday, December 10th.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Silverlake Wealth Management LLC acquired a new stake in Tilray Brands in the 3rd quarter worth about $25,000. Oppenheimer & Co. Inc. purchased a new position in shares of Tilray Brands in the third quarter valued at approximately $25,000. Unified Investment Management purchased a new position in shares of Tilray Brands in the third quarter valued at approximately $26,000. J.W. Cole Advisors Inc. boosted its stake in shares of Tilray Brands by 203.2% in the second quarter. J.W. Cole Advisors Inc. now owns 71,890 shares of the company’s stock worth $30,000 after acquiring an additional 48,177 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd acquired a new stake in shares of Tilray Brands in the third quarter worth approximately $30,000. 9.35% of the stock is owned by hedge funds and other institutional investors.

Tilray Brands News Roundup

Here are the key news stories impacting Tilray Brands this week:

• Positive Sentiment: Tilray completed the acquisition of BrewDog’s Australian brewing and bar assets, giving it a profitable operational base (brewery + flagship bars) to scale across Australia and the Asia‑Pacific — a direct step to grow its beverage and CPG business beyond North America. Tilray Brands Acquires BrewDog Australia
• Positive Sentiment: Management is projecting much larger top-line growth (Tilray expects roughly $1.2B in revenue next year) driven by acquisitions and expanded beverage distribution; management also cites BrewDog-related revenue targets (e.g., ~$200M annual net revenue from UK operations by FY2027), supporting the company’s multi‑brand growth thesis. Tilray Brands Expects to Generate $1.2 Billion
• Neutral Sentiment: Broader industry coverage highlights continued global legalization and investor interest in Canadian cannabis names, which can support long‑term demand assumptions for diversified cannabis/CPG players like Tilray but does not change near‑term company fundamentals. Canadian Cannabis Stocks to Watch in March 2026
• Negative Sentiment: Analyst commentary and investor debate flag near‑term execution risk: integration costs, margin pressure and the need to prove Project 420 synergies. Recent writeups call Tilray a “hold” until synergies materialize. The company still reports negative net margins and ROE, and some analysts model negative EPS for the current fiscal year — all factors that can prompt profit‑taking and keep the stock under pressure. Tilray’s Going To Be Great, But For Now It’s A Hold

Tilray Brands Price Performance

Shares of Tilray Brands stock opened at $7.20 on Wednesday. The firm has a market cap of $838.87 million, a PE ratio of -0.33 and a beta of 1.96. Tilray Brands has a twelve month low of $3.51 and a twelve month high of $23.20. The company has a quick ratio of 1.72, a current ratio of 2.81 and a debt-to-equity ratio of 0.19. The business has a 50-day moving average price of $8.22 and a 200 day moving average price of $10.90.

Tilray Brands (NASDAQ:TLRY) last issued its quarterly earnings results on Thursday, January 8th. The company reported ($0.02) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.12. Tilray Brands had a negative return on equity of 6.35% and a negative net margin of 251.69%.The company had revenue of $217.51 million for the quarter, compared to the consensus estimate of $211.15 million. During the same quarter in the prior year, the business posted ($0.03) earnings per share. Sell-side analysts predict that Tilray Brands will post -0.2 earnings per share for the current fiscal year.

About Tilray Brands

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.